RRM2 and pancreatic adenocarcinoma: RRM2 enhances the invasive capacity of pancreatic adenocarcinoma cells in a NF-kappaB-dependent manner[24], and RRM2 overexpression can increase angiogenesis by down-regulating thrombspondin-1 and increasing production of VEGF[25].